Nearly 12% Of Americans Have Used Glp-1 Weight Loss Drugs

Nearly 12% of Americans person utilized GLP-1 narcotics for weight loss, including astir one-fifth of women aged 50 to 64, according to a caller RAND report.

Surveying a nationally typical sample of 8,793 Americans, researchers recovered that 11.8% person utilized GLP-1 agonists and 14% opportunity they are willing successful utilizing nan drugs. Meanwhile, 74% opportunity they do not scheme to return nan medications.

Among those who person utilized GLP-1 drugs, astir half study they person knowledgeable nausea and astir one-third knowledgeable diarrhea -- nan 2 most-common broadside effects associated pinch nan medications.

The study is nan most-recent and largest study to day that estimates really galore Americans person utilized nan narcotics that person revolutionized weight nonaccomplishment care. The study outlines usage of GLP-1 narcotics by some property and sex.

The usage of Ozempic and different GLP-1 medications has accrued sharply successful caller years since studies demonstrated nan narcotics tin thief group importantly assistance weight loss. Since 2020, nan number of prescriptions for nan narcotics has much than tripled.

RAND researchers surveyed participants of nan RAND American Life Panel to inquire astir usage of GLP-1 narcotics and their experiences pinch broadside effects. The study was performed during April and May of 2025.

The results show that women thin to usage GLP-1 narcotics astatine higher rates than men, though location is sizeable variability wrong property groups.

Use of GLP-1 narcotics is astir communal among those betwixt nan ages of 50 and 64, pinch nan highest complaint of usage recovered among women successful nan property group. Among those 65 and older, usage of GLP-1 narcotics is somewhat higher for men than for women. Conversely, among those betwixt nan ages of 30 and 49, women are much than doubly arsenic apt to person utilized a GLP-1 than their antheral peers.

The RAND American Life Panel is simply a probability sample-based study sheet of astir 11,000 active, regularly interviewed respondents aged 12 and older. The sheet was developed by RAND successful 2006.

The report, "New Weight Loss Drugs: GLP-1 Agonist Use and Side Effects successful nan United States," is disposable astatine www.rand.org. Authors of nan study are Robert Bozick, Shannon Donofry and Katherine M. Rancaño.

The publication is nan first successful what is planned to beryllium a bid of little reports that highlights topline descriptive findings from surveys tally connected nan RAND American Life Panel.

The RAND Education and Labor section is dedicated to improving acquisition and expanding economical opportunities for each done investigation and analysis.